PHPhillip Huyett

Phillip Huyett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Phillip Huyett has a total of 268 co-authors. Here are the top co-authors by number of shared publications:

  • Katherine K. Green

    Department of Otolaryngology–Head and Neck Surgery University of Colorado School of Medicine Aurora Colorado U.S.A.

    4 shared publications
  • Maria V. Suurna

    University of Miami Health System Miami Florida USA

    4 shared publications
  • Amy E. Schell

    Department of Otolaryngology–Head and Neck Surgery University of Colorado School of Medicine Aurora Colorado U.S.A.

    3 shared publications
  • Colin Huntley

    Thomas Jefferson University Sidney Kimmel Medical College Philadelphia Pennsylvania USA

    3 shared publications
  • Daniel Vena

    Division of Sleep and Circadian Disorders, Department of Medicine and Neurology, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA

    3 shared publications
  • David T. Kent

    Department of Otolaryngology‐Head and Neck Surgery Vanderbilt University Medical Center Nashville Tennessee USA

    3 shared publications

Latest Publications

  • Open Access

    Anthropometric Measurements Inform Complete Concentric Collapse Status in Patients With Obstructive Sleep Apnea

    by Jordan S. Weiner, Eugene G. Chio, Raj C. Dedhia, Colin T. Huntley, Michael J. Hutz, Phillip Huyett, Daniel J. Lee, Philip LoSavio, Ilya Perepelitsyn, Ryan J. Soose, et al.

    Objective: Hypoglossal nerve stimulation in the US requires drug‐induced sleep endoscopy to exclude patients with complete concentric collapse. This is an expensive and time‐consuming requirement. We hypothesized that supine pharyngeal width, and other demographic and polysomnographic variables would associate with complete concentric collapse. Study Design: Prospective, multicenter cohort study. Setting: 10 centers in the United States with experience selecting patients for and performing airway surgeries for sleep apnea including hypoglossal nerve stimulation implantation. Methods: 600 patients meeting criteria for hypoglossal nerve stimulation underwent measurement of supine pharyngeal width and collection of demographic and polysomnographic data followed by drug‐induced sleep endoscopy. Results: 587 patients completed the study. Patients with complete concentric collapse had a higher body mass index (31.2 ± 3.2 vs 29.0 ± 3.4 kg/m 2 , P < .001), larger neck circumference (45.5 ± 4.2 vs 40.6 ± 4.7 cm, P < .001), and lower supine pharyngeal width (19.4 ± 6.3 vs 21.8 ± 6.5 mm; P = .008) than patients without complete concentric collapse. Conclusion: Body mass index, neck circumference, and supine pharyngeal width all associate with complete concentric collapse and could potentially be used to determine hypoglossal nerve stimulation candidacy instead of drug‐induced sleep endoscopy for most patients thereby reducing both time and cost. (ClinicalTrials.gov NCT05428839: https://clinicaltrials.gov/study/NCT05428839?term=Inspire%20Medical%20systems%20predictor&rank=1 ).

  • The impact of nasal mask versus oronasal mask CPAP treatment on the site of collapse and the differences in physiologic state

    by Jongmin Kim, David Koo, Chung Man Sung, Jisun Kim, Seung Soo Ryu, Sang Chul Lim, D. Andrew Wellman, Daniel Vena, Phillip Huyett, Hyung Chae Yang

    Purpose The type of mask, either oronasal or nasal, is known to influence the efficacy of Continuous Positive Airway Pressure (CPAP) therapy. Previous studies have examined mask effects on either anatomical airway changes or clinical outcomes, but none have simultaneously assessed anatomical and physiological impacts within the same patients. To our knowledge, this study is the first randomized crossover trial to investigate how mask type influences both airway collapse and oxygenation across CPAP pressure levels. Methods We conducted a prospective randomized controlled crossover trial including 30 adults with obstructive sleep apnea (OSA) confirmed by polysomnography. Each patient underwent drug-induced sleep endoscopy (DISE) while receiving CPAP with both nasal and oronasal masks in random order. Airway obstruction was evaluated using the VOTE classification, pharyngeal opening pressures (PhOP) were measured, and oxygen saturation (SpO₂) was monitored across CPAP levels. Results A total of 27 patients were included in the final analysis (mean age 54.3 ± 15.2 years; median AHI 29.6 [IQR: 10.6–53.9]/h). Compared with oronasal masks, nasal masks more effectively relieved obstruction at the velum, oropharynx, and tongue base at therapeutic pressures and required significantly lower PhOP values at the velum and tongue base. Moreover, nasal masks maintained higher SpO2 within the therapeutic range (6–12 cmH2O). Conclusion Nasal masks were more effective than oronasal masks in reducing airway obstruction and maintaining oxygenation during CPAP therapy, suggesting anatomical and physiological advantages that may guide personalized mask selection in OSA management.


  • Efficiency and Safety of Obstructive Sleep Apnea Cases Performed in an Ambulatory Surgery Center

    by Samantha M. Shave, Phoebe Yu, Victoria Caruso, Gustavo Lozada, Fred Shapiro, Justin Benoit, Phillip Huyett

    Objective: Patients with obstructive sleep apnea (OSA) have increased perioperative risk, and procedures for OSA have traditionally been performed in a full‐service, hospital‐based operative room (HOR) often with inpatient admission postoperatively. We sought to compare the efficiency and safety of outpatient drug‐induced sleep endoscopy (DISE), expansion pharyngoplasty (EP), hypoglossal nerve stimulation (HGNS), and septoplasty performed in patients with OSA in an ambulatory surgery center (ASC) versus HOR. Study Design: Retrospective Cohort Study. Methods: Patients who underwent DISE, HGNS, septoplasty, tonsillectomy, and EP performed between January 1, 2021 and July 8, 2023 at a single academic HOR and ASC were included. We compared patient characteristics, in‐room duration, recovery room times, and complications by surgical location. Results: One thousand two hundred seventy‐three patients were identified; 727 underwent isolated DISE, 341 HGNS, 76 EP, 42 tonsillectomy, and 86 septoplasties. There were no significant baseline demographic differences between patients treated at the ASC as compared to the HOR except for a higher mean BMI (29.6 vs. 28.6 kg/m 2 , p < 0.001) at the HOR. In‐OR times in the ASC were no different than in the main OR for all procedures except HGNS, which, on average, took 4.0 min longer at the HOR ( p = 0.03). Recovery room times at the ASC were significantly shorter for all procedures. There were very low rates of 30‐day re‐admissions and ER visits for procedures performed in both settings. Conclusions: The OSA procedures analyzed in this study can safely be performed in an ASC with significantly reduced PACU times. Further research is needed to determine patient characteristics compatible with safe ambulatory OSA procedures. Level of Evidence: 3.

  • Positive Airway Pressure Therapy for Obstructive Sleep Apnea in High‐Risk Pregnancy: A Meta‐Analysis

    by Thamiris D. D. Cabral, Renata M. Knoll, Jaime Plane, Patricia Viana, Bruno Dalla Vecchia Vendramini, João Evangelista Ponte Conrado, Victoria Caruso, Phillip Huyett

    Objectives: We aimed to assess the effects of positive airway pressure (PAP) therapy in high‐risk pregnancy patients with OSA. Data Sources: Studies were systematically searched on PubMed, Embase, Web of Science, and Cochrane Library. Review Methods: Articles comparing PAP therapy to no treatment or non‐PAP treatment modalities, such as waitlist, sham PAP, and nasal dilator strips in high‐risk pregnancy patients with OSA were included. Outcomes of interest included fasting plasma glucose (FPG), estimated insulin resistance, gestational diabetes, blood pressure measurements, hypertensive disorders of pregnancy, cesarean section, Epworth Sleepiness Scale, birth weight, Apgar at 1 and 5 min, preterm delivery, fetal growth abnormalities, and neonatal intensive care unit admission. Mean difference (MD) was used for continuous outcomes and risk ratio for binary endpoints, with 95% confidence intervals (CI). Results: Seven studies involving 696 patients were included, of which 328 patients were treated with PAP therapy. PAP therapy was associated with lower FPG (MD −6.50, 95% CI −10.64 to −2.36, p = 0.002, I 2 = 3.2%) and improved insulin resistance, as indicated by reduced HOMA‐IR levels (MD −0.90, 95% CI −1.15 to −0.65, p < 0.01; I 2 = 0%). No significant differences were observed in other maternal or neonatal outcomes. Conclusion: Our findings suggest PAP therapy may benefit high‐risk pregnant women with OSA by improving certain maternal outcomes related to glucose metabolism, while effects on other maternal and neonatal outcomes are limited.


  • The Use of Acetazolamide in a Sleep Surgery Practice

    by Phillip Huyett, Andrew Wellman

    Central sleep apnea is commonly encountered in sleep surgical practices. In this How I Do It, we describe 3 different scenarios in which the off-label use of acetazolamide therapy has been effectively used to treat central sleep apnea in a sleep surgical practice.

  • Lateral Axillary Approach for Placement of the Fifth‐Generation Hypoglossal Nerve Stimulator Implantable Pulse Generator

    by Phillip Huyett, Maria V. Suurna

    Hypoglossal nerve stimulation has become an increasingly popular treatment for obstructive sleep apnea. Some patients express concerns about the appearance of the anterior chest incision scar. Here, we describe the feasibility of the lateral axillary approach for placing the fifth‐generation implantable pulse generator, which does not require a respiratory sensor. The first three patients were successfully implanted, had excellent respiratory waveforms, and had no complications. The surgical times were not substantially different than for implanting the fourth‐generation or fifth‐generation device through a standard anterior chest incision.


  • Impact of the Connected Sleep Remote on Early Adherence to Hypoglossal Nerve Stimulation Therapy

    by Phoebe K. Yu, Phillip Huyett

    Objectives: To assess the impact of the connected sleep remote on early adherence to therapy with hypoglossal nerve stimulation therapy.Methods: Prospective cohort study. Objective adherence data was extracted from a cloud‐based database on consecutive patients undergoing implantation of unilateral hypoglossal nerve stimulation before and after the introduction of the connected sleep remote.Results: We identified 121 patients with the original sleep remote and 126 patients with the connected sleep remote in the 12 months before and after the introduction of the connected remote, respectively. Overall usage in the first 7 days was 7.9 h, with therapy used on 95.3% of nights and 0.6 pauses per night. Usage in the first 30 days was 7.7 h, with therapy used on 94.0% of nights and 0.6 h of pause per night. There were no differences between the original and connected sleep remotes at 7, 14, 30, or 60 days. By 90 days, nightly usage was 7.3 h for both groups, but the percentage of nightly usage was higher with the connected remote group at 94.2% compared to the original remote group at 89.2% (p = 0.03). In multivariable analysis, the connected remote was associated with a higher percentage of nightly usage in the first 90 days. There were no differences in early adherence rates between therapy responders and non‐responders.Conclusion: A connected sleep remote allowing remote physician as well as direct patient access to usage data was associated with higher adherence at 90 days, possibly reflecting positive reinforcement provided by the associated smartphone application.Level of Evidence: 3.


  • Adults with Down syndrome and obstructive sleep apnea treated with hypoglossal nerve stimulation

    by Phillip Huyett, Stephanie L. Santoro, Nicolas M. Oreskovic, Brian G. Skotko

    To examine the feasibility, adherence to therapy, and efficacy of hypoglossal nerve stimulation (HGNS) in adults with Down syndrome (DS) with obstructive sleep apnea. Adults patients with DS who met criteria for hypoglossal nerve stimulation were prospectively enrolled. Objective adherence was extracted from a cloud-based compliance database. Pre-operative sleep studies were compared to follow-up testing performed no sooner than 3 months after device activation. Eleven adults with DS underwent implantation of HGNS between May 2021 and July 2024. Median age was 27 years old (interquartile range 26, 33), BMI 28.5kg/m2 (26.5, 32.4), 27% were female, and had severe OSA (apnea-hypopnea index (AHI) 40/hr, (28.4, 42.9)). All patients were successfully implanted on an outpatient basis with no post-operative complications or readmissions and activated on schedule at 1 month after surgery. Adherence data show nightly usage longer than 4 hours was 100% and 96% of nights and a median of 9.2 and 8.5 hours/night in the first 30 and 90 days, respectively. Seven patients have undergone follow up testing and the median entire night AHI was reduced by 76%. All patients experienced a >50% decrease in AHI and to less than 15/hr. Median time spent below 88% improved from 2.0% (0.3,5.0) to 0.2% (0,0.6), and oxygenation nadir improved from 79.0% (75.5,85) to 88.0% (86.5,91). In this small initial cohort, HGNS appears to be a safe, well-tolerated and efficacious treatment option for adults with DS with moderate-severe obstructive sleep apnea and positive airway pressure therapy intolerance.


  • Immediate Postoperative Changes After Expansion Pharyngoplasty and Hypoglossal Nerve Stimulation

    by Phoebe K. Yu, Victoria Wong, Kaitlyn Cook, Phillip Huyett

    Objective: Patients with obstructive sleep apnea (OSA) are at an increased risk for perioperative cardiopulmonary complications. Our objective was to assess the postoperative effects of hypoglossal nerve stimulation implantation (HGNS) and expansion pharyngoplasty (EP) on longitudinal sleep apnea measures as a surrogate for respiratory complications. Study Design: Prospective longitudinal cohort study of patients with OSA undergoing HGNS or EP. Methods: Sleep studies were performed with the NightOwl Mini peripheral arterial tonometry (PAT) device. Changes in apnea‐hypopnea index (AHI) and oximetry time below 90% (T90) were assessed between two baseline PAT studies prior to surgery and nightly PAT studies for the first postoperative nights (PON) 1–7, 10, and 14. Results: Thirty patients were enrolled (19 HGNS, 11 EP). The mean age was 52.6 years, 76.7% were male, and the mean clinical baseline AHI was 29.8/h. There were no significant changes in the AHI or T90 following HGNS implantation. Following EP, there was a statistically significant mean increase in AHI of +19.2/h on PON1, +24.9/h on PON2, and + 20/h on PON3 compared to baseline. T90 was also elevated after EP on PON1, 4, and 5. The mean increase in T90 was +7.4% (95% CI 2.9, 11.9) on PON1 compared to baseline. Conclusions: In the immediate postoperative period, there were no significant changes in AHI or hypoxemia after HGNS, suggesting that there is no need for routine overnight observation after HGNS. There were significant increases in AHI and hypoxemia after EP suggesting that postoperative disposition should be considered on a case‐by‐case basis. Level of Evidence: 3 Laryngoscope , 135:1836–1842, 2025